Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZD2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,332
Award facts
- Contract value 100% obligated
- $19,332.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,332.22 by the Defense Logistics Agency on December 31, 2025. This delivery order, issued without set-aside designation, is for the supply of Trikafta 100-50-75 mg/150 mg, with an ultimate completion date of January 2, 2026. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.999 billion ceiling value and completion date of December 31, 2036.
The PPV-G GEN V program represents part of the Department of Defense's comprehensive $30.3 billion pharmaceutical supply chain strategy to provide military healthcare facilities worldwide with branded and generic prescription drugs, biologics, and medical consumables. As a prime vendor contractor under this vehicle, DMS Pharmaceutical Group has demonstrated consistent performance across numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division, positioning the company as a critical supplier for DoD healthcare operations. The contract structure authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for the full range of pharmaceutical products required to support recurring medical supply needs across the military medical system globally.
Quick answers
Who was awarded contract SPE2DR26FCZD2?
SPE2DR26FCZD2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FCZD2 worth?
The government has obligated $19,332 on SPE2DR26FCZD2.
Is contract SPE2DR26FCZD2 an order under another contract?
Yes. SPE2DR26FCZD2 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZD2 competed?
The extent of competition for SPE2DR26FCZD2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award